Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buspirone for Recurrent Central Apneas in Heart Failure
NCT00746954Phase 3Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Sep 2008
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of buspirone in central sleep apnea (CSA) (3 arms), sponsored by VA Office of Research & Development. Primary endpoint: Apnea-Hypopnea Index. Started Sep 2008; status: terminated.
02
Drugs
buspirone
03
Conditions
central sleep apnea (CSA)
Beyond the preview
Go deeper on NCT00746954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746954.